Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
70.60B | 71.20B | 71.67B | 69.79B | 59.44B | 55.81B | Gross Profit |
14.49B | 14.76B | 15.04B | 14.43B | 14.73B | 14.00B | EBIT |
-510.00M | -293.00M | 368.00M | -1.14B | -40.00M | -383.00M | EBITDA |
3.77B | 3.38B | 5.73B | 1.38B | 2.28B | 2.81B | Net Income Common Stockholders |
2.55B | -29.00M | 3.22B | -1.10B | 389.00M | 951.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
7.44B | 8.74B | 13.42B | 6.95B | 6.60B | 9.32B | Total Assets |
89.74B | 88.71B | 96.12B | 92.98B | 88.85B | 80.67B | Total Debt |
24.49B | 24.52B | 25.33B | 26.60B | 24.28B | 16.68B | Net Debt |
18.04B | 16.78B | 12.53B | 19.65B | 17.68B | 8.37B | Total Liabilities |
48.09B | 46.92B | 53.31B | 53.46B | 47.05B | 38.46B | Stockholders Equity |
43.96B | 44.25B | 44.52B | 40.61B | 42.18B | 42.30B |
Cash Flow | Free Cash Flow | ||||
0.00 | -4.21B | 8.15B | -1.92B | -10.12B | -8.93B | Operating Cash Flow |
0.00 | -2.31B | 9.95B | 263.00M | 1.21B | 4.12B | Investing Cash Flow |
0.00 | -2.15B | -1.77B | -662.00M | -9.56B | -10.59B | Financing Cash Flow |
0.00 | -1.23B | -1.70B | 915.00M | 6.80B | 9.59B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | ¥24.72B | 14.06 | 5.37% | 1.57% | 20.22% | ||
72 Outperform | ¥5.86B | 57.71 | 2.48% | 4.82% | -89.34% | ||
65 Neutral | ¥8.32B | 8.02 | 5.07% | 8.65% | 84.06% | ||
65 Neutral | ¥7.69B | 4.31 | 2.92% | 0.58% | ― | ||
62 Neutral | $6.90B | 11.05 | 2.80% | 4.27% | 2.67% | -24.92% | |
55 Neutral | ¥7.70B | 117.73 | 5.75% | 2.17% | -101.54% | ||
52 Neutral | ¥9.68B | 3.86 | 4.57% | -0.65% | -100.90% |